Omega Therapeutics, Inc. 8-K SEC Filings

Filed On	Filing
24 Feb 2025	8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule
14 Feb 2025	8-K: Entry into a Material Definitive Agreement; Bankruptcy or Receivership +1 more
03 Feb 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +4 more
28 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
17 Jan 2025	8-K: Triggering Events That Accelerate a Financial Obligation
10 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
31 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
06 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation
14 Nov 2024	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
04 Oct 2024	8-K: Departure/Election of Directors or Officers; Compensation
30 Aug 2024	8-K: Entry into a Material Definitive Agreement
06 Aug 2024	8-K: Results of Operations and Financial Condition
24 Jun 2024	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
30 May 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
06 May 2024	8-K: Results of Operations and Financial Condition
16 Apr 2024	8-K: Departure/Election of Directors or Officers; Compensation
28 Mar 2024	8-K: Results of Operations and Financial Condition
05 Jan 2024	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
11 Dec 2023	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
09 Nov 2023	8-K: Results of Operations and Financial Condition

Comments